Publications by Dr Laura Gamble - ePrints

Browsing publications by Dr Laura Gamble.

Newcastle Authors	Title	Year
Dr Laura Gamble Dr Holly Bennett Professor Fiona Matthews	A comparison of well-being of carers of people with dementia and their ability to manage before and during the COVID-19 pandemic: findings from the IDEAL study	2022
Dr Laura Gamble Professor Fiona Matthews	Characteristics of people living with undiagnosed dementia: findings from the CFAS Wales study	2022
Dr Laura Gamble Professor Fiona Matthews	Longitudinal trajectories of quality of life among people with mild-to-moderate dementia: a latent growth model approach with IDEAL cohort study data	2022
Dr Holly Bennett Dr Laura Gamble Professor Fiona Matthews	Minimal Impact of COVID-19 Pandemic on the Mental Health and Wellbeing of People Living With Dementia: Analysis of Matched Longitudinal Data From the IDEAL Study	2022
Dr Laura Gamble Dr Yu-Tzu Wu Professor Fiona Matthews	The Use and Costs of Paid and Unpaid Care for People with dementia: Longitudinal Findings from the IDEAL cohort	2022
Dr Laura Gamble Dr Louise Allan Professor Fiona Matthews	Impact of COVID-19 on 'living well' with mild-to-moderate dementia in the community: findings from the IDEAL cohort	2021
Dr Laura Gamble Professor Fiona Matthews	Psychological processes in adapting to dementia: illness representations among the IDEAL cohort	2021
Dr Laura Gamble	Trajectories of socio-emotional functioning in early-stage dementia: implications for the individual with dementia and their family carer	2021
Dr Laura Gamble Professor Fiona Matthews	Living Alone with Mild-To-Moderate Dementia: Findings from the IDEAL Cohort	2020
Dr Laura Gamble	Targeting Metabolic Activity in High-Risk Neuroblastoma Through Monocarboxylate Transporter 1 (MCT1) Inhibition	2020
Dr Laura Gamble	Inhibition of Polyamine Synthesis and Uptake Reduces Tumor Progression and Prolongs Survival in Mouse Models of Neuroblastoma	2019
Livingstone Fultang Dr Laura Gamble	Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma	2019
Dr Laura Gamble	Suppression of the ATP-binding Cassette Transporter ABCC4 Impairs Neuroblastoma Tumour Growth and Sensitises to Irinotecan in Vivo	2017
Dr Laura Gamble	MYCN Promotes Neuroblastoma Malignancy by Establishing a Regulatory Circuit With Transcription Factor AP4	2016
Dr Laura Gamble	Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression	2016
Dr Laura Gamble	Therapeutic Targeting of the MYC Signal by Inhibition of Histone Chaperone FACT in Neuroblastoma	2015
Dr Jane Carr-Wilkinson Bojidar Goranov Dr Chris Redfern Dr Laura Gamble Professor John Lunec et al.	Outcome of the p53-mediated DNA damage response in neuroblastoma is determined by morphological subtype and MYCN expression	2011
Dr Lindi Chen Dr Laura Gamble Professor John Lunec Professor Deborah Tweddle	p53 is a direct transcriptional target of MYCN in neuroblastoma	2010